Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian CancerHui Zhang, Karl R. Klauser, Jianying Zhou et al.|Cell|2016Cited by 1.1k
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian CarcinomaYingwei Hu, Melinda E. Sanders, Jianbo Pan et al.|Cell Reports|2020Cited by 155
Global Proteomic Determination of the Poly-Pharmacological Effects of PARP Inhibitors Following Treatment of High-Grade Serous Ovarian Cancer CellsJesenia M. Perez, Stefani N. Thomas|International Journal of Molecular Sciences|2025Cited by 0